Oliman, Jenny .

HRN: 23-06-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2023
CEFUROXIME 1.5GM (VIAL)
05/16/2023
05/22/2023
IVT
270mg
Q8
PCAP C
Waiting Final Action 
05/20/2023
CEFTRIAXONE 1G (VIAL)
05/20/2023
05/26/2023
IVT
320mg
Q12
Pcap C
Waiting Final Action 
05/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/20/2023
05/26/2023
IVT
120mg
OD
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: